Pimozide cf. Haloperidol in Tourette Syndrome
Abstract
Pimozide (3.4 mg/day) and haloperidol (3.5 mg/day) therapy for Tourette syndrome were compared in a double-blind, 24-week, placebo-controlled crossover study of 22 patients, aged 7-16 years, at the Institute of Psychiatry, Charleston, SC.
DOI: https://doi.org/10.15844/pedneurbriefs-11-8-6 | Journal eISSN: 2166-6482
Language: English
Page range: 59 - 60
Published on: Aug 1, 1997
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.